Effects of apoE isoforms on beta-amyloid-induced matrix metalloproteinase-9 in rat astrocytes

Shuzhen Guo1, Sophia Wang, Woo Jean Kim

  • 1Department of Neurology, Mass General Hospital, Charlestown, MA, USA.

Brain Research
|August 22, 2006
PubMed

Insights

The Apolipoprotein E4 (APOE4) isoform may hinder Alzheimer's disease (AD) progression by reducing beta-amyloid (Abeta) clearance. This suggests APOE4 dampens the inflammatory response, potentially impacting Abeta deposition in AD.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Biochemistry

Background:

  • Matrix metalloproteinase-9 (MMP-9) is implicated in the inflammatory glial response in Alzheimer's disease (AD).
  • Astrocytes, a type of glial cell, can degrade beta-amyloid (Abeta), a key protein in AD pathology.
  • Extracellular proteolysis mediated by MMP-9 may be involved in Abeta degradation by astrocytes.

Purpose of the Study:

  • To investigate the influence of different Apolipoprotein E (APOE) isoforms on Abeta-induced MMP-9 responses in primary rat astrocytes.
  • To determine if APOE genotype affects the expression or activity of MMP-9 in astrocytes exposed to Abeta.

Main Methods:

  • Primary rat astrocytes were cultured and treated with beta-amyloid (Abeta).
  • The expression levels of Matrix metalloproteinase-9 (MMP-9) were measured in response to Abeta exposure.
  • The effect of different Apolipoprotein E (APOE) isoforms (including APOE4) on Abeta-induced MMP-9 levels was analyzed.
  • The involvement of the Rho-Rho kinase (ROCK) pathway was investigated.

Main Results:

  • Apolipoprotein E4 (APOE4) significantly reduced Abeta-induced MMP-9 levels in primary rat astrocytes.
  • The dampening effect of APOE4 on MMP-9 was potentially mediated by the downregulation of the Rho-Rho kinase (ROCK) pathway.
  • These findings suggest that APOE4 influences the proteolytic activity of astrocytes.

Conclusions:

  • APOE4 may impair the clearance of Abeta by astrocytes by reducing MMP-9 activity.
  • This reduction in astrocytic MMP-9 could contribute to increased Abeta deposition in Alzheimer's disease.
  • The APOE genotype plays a crucial role in modulating the glial response and Abeta metabolism in AD.

Related Concept Videos